US Stock MarketDetailed Quotes

CNBX Pharmaceuticals (CNBX)

Watchlist
  • 0.0002
  • -0.0001-20.00%
15min DelayClose Jan 22 15:42 ET
174.15KMarket Cap0.20P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CNBX Pharmaceuticals (CNBX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Nov 30, 2025
(FY)Aug 31, 2025
(Q4)Aug 31, 2025
(Q3)May 31, 2025
(Q2)Feb 28, 2025
(Q1)Nov 30, 2024
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
(Q2)Feb 29, 2024
Total revenue
0
0
0
0
0
0
-68.29%130.07K
0
0
40.64K
Operating revenue
--0
--0
--0
--0
--0
--0
-68.29%130.07K
--0
--0
--40.64K
Cost of revenue
0
6.22K
Gross profit
0
34.42K
Operating expense
73.74%64K
-61.91%271.69K
146.95%129.73K
-73.48%40.38K
-73.12%64.74K
-85.90%36.84K
-46.84%713.21K
-79.91%52.53K
-68.49%152.28K
-3.67%240.85K
Selling and administrative expenses
73.74%64K
-47.59%271.69K
2.58%129.73K
-63.09%40.38K
-51.56%64.74K
-75.26%36.84K
-43.03%518.43K
-24.84%126.47K
-50.31%109.39K
-43.77%133.65K
-Selling and marketing expense
----
----
----
----
----
----
--0
----
----
----
-General and administrative expense
73.74%64K
-47.59%271.69K
2.58%129.73K
-63.09%40.38K
-51.56%64.74K
-75.26%36.84K
-42.95%518.43K
-24.29%126.47K
-50.31%109.39K
-43.77%133.65K
Research and development costs
----
--0
--0
--0
--0
--0
-54.86%194.79K
-179.30%-73.93K
-83.70%42.88K
769.56%107.2K
Operating profit
-73.74%-64K
53.41%-271.69K
-146.95%-129.73K
73.48%-40.38K
68.64%-64.74K
78.57%-36.84K
37.39%-583.14K
67.47%-52.53K
12.02%-152.28K
17.43%-206.43K
Net non-operating interest income expense
-2,100.68%-49.72K
-104.93%-40.19K
-302.95%-18.28K
-189.38%-19.35K
-207.80%-5.05K
137.52%2.49K
64.97%-19.61K
94.63%-4.54K
17.69%21.65K
-77.70%4.68K
Non-operating interest expense
----
104.93%40.19K
----
----
----
----
1,570.44%19.61K
----
----
----
Total other finance cost
2,100.68%49.72K
----
----
189.38%19.35K
207.80%5.05K
-137.52%-2.49K
----
----
-17.69%-21.65K
77.70%-4.68K
Other net income (expense)
97.73%-2.1K
96.60%-92.45K
98.93%-3.51K
94.84%-123.71K
Gain on sale of security
----
40.34%-2.1K
----
----
----
----
-204.52%-3.51K
----
----
----
Special income (charges)
----
--0
--0
--0
--0
----
96.74%-88.93K
--0
--0
94.84%-123.71K
-Gain on sale of property,plant,equipment
----
--0
--0
--0
--0
----
96.74%-88.93K
--0
--0
94.84%-123.71K
Income before tax
-231.04%-113.72K
54.84%-313.98K
-147.77%-150.11K
54.28%-59.73K
78.56%-69.79K
80.76%-34.35K
81.26%-695.2K
89.44%-60.58K
15.55%-130.63K
87.60%-325.46K
Income tax
Net income
-231.04%-113.72K
54.84%-313.98K
-147.77%-150.11K
54.28%-59.73K
78.56%-69.79K
80.76%-34.35K
81.26%-695.2K
89.44%-60.58K
15.55%-130.63K
87.60%-325.46K
Net income continuous Operations
-231.04%-113.72K
54.84%-313.98K
-147.77%-150.11K
54.28%-59.73K
78.56%-69.79K
80.76%-34.35K
81.26%-695.2K
89.44%-60.58K
15.55%-130.63K
87.60%-325.46K
Minority interest income
Net income attributable to the parent company
-231.04%-113.72K
54.84%-313.98K
-147.77%-150.11K
54.28%-59.73K
78.56%-69.79K
80.76%-34.35K
81.26%-695.2K
89.44%-60.58K
15.55%-130.63K
87.60%-325.46K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-231.04%-113.72K
54.84%-313.98K
-147.77%-150.11K
54.28%-59.73K
78.56%-69.79K
80.76%-34.35K
81.26%-695.2K
89.44%-60.58K
15.55%-130.63K
87.60%-325.46K
Basic earnings per share
0
0
-0.0003
0
0
83.33%-0.001
95.24%-0.02
0
0
99.25%-0.01
Diluted earnings per share
0
0
-0.0003
0
0
83.33%-0.001
95.24%-0.02
0
0
99.25%-0.01
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Nov 30, 2025(FY)Aug 31, 2025(Q4)Aug 31, 2025(Q3)May 31, 2025(Q2)Feb 28, 2025(Q1)Nov 30, 2024(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024(Q2)Feb 29, 2024
Total revenue 000000-68.29%130.07K0040.64K
Operating revenue --0--0--0--0--0--0-68.29%130.07K--0--0--40.64K
Cost of revenue 06.22K
Gross profit 034.42K
Operating expense 73.74%64K-61.91%271.69K146.95%129.73K-73.48%40.38K-73.12%64.74K-85.90%36.84K-46.84%713.21K-79.91%52.53K-68.49%152.28K-3.67%240.85K
Selling and administrative expenses 73.74%64K-47.59%271.69K2.58%129.73K-63.09%40.38K-51.56%64.74K-75.26%36.84K-43.03%518.43K-24.84%126.47K-50.31%109.39K-43.77%133.65K
-Selling and marketing expense --------------------------0------------
-General and administrative expense 73.74%64K-47.59%271.69K2.58%129.73K-63.09%40.38K-51.56%64.74K-75.26%36.84K-42.95%518.43K-24.29%126.47K-50.31%109.39K-43.77%133.65K
Research and development costs ------0--0--0--0--0-54.86%194.79K-179.30%-73.93K-83.70%42.88K769.56%107.2K
Operating profit -73.74%-64K53.41%-271.69K-146.95%-129.73K73.48%-40.38K68.64%-64.74K78.57%-36.84K37.39%-583.14K67.47%-52.53K12.02%-152.28K17.43%-206.43K
Net non-operating interest income expense -2,100.68%-49.72K-104.93%-40.19K-302.95%-18.28K-189.38%-19.35K-207.80%-5.05K137.52%2.49K64.97%-19.61K94.63%-4.54K17.69%21.65K-77.70%4.68K
Non-operating interest expense ----104.93%40.19K----------------1,570.44%19.61K------------
Total other finance cost 2,100.68%49.72K--------189.38%19.35K207.80%5.05K-137.52%-2.49K---------17.69%-21.65K77.70%-4.68K
Other net income (expense) 97.73%-2.1K96.60%-92.45K98.93%-3.51K94.84%-123.71K
Gain on sale of security ----40.34%-2.1K-----------------204.52%-3.51K------------
Special income (charges) ------0--0--0--0----96.74%-88.93K--0--094.84%-123.71K
-Gain on sale of property,plant,equipment ------0--0--0--0----96.74%-88.93K--0--094.84%-123.71K
Income before tax -231.04%-113.72K54.84%-313.98K-147.77%-150.11K54.28%-59.73K78.56%-69.79K80.76%-34.35K81.26%-695.2K89.44%-60.58K15.55%-130.63K87.60%-325.46K
Income tax
Net income -231.04%-113.72K54.84%-313.98K-147.77%-150.11K54.28%-59.73K78.56%-69.79K80.76%-34.35K81.26%-695.2K89.44%-60.58K15.55%-130.63K87.60%-325.46K
Net income continuous Operations -231.04%-113.72K54.84%-313.98K-147.77%-150.11K54.28%-59.73K78.56%-69.79K80.76%-34.35K81.26%-695.2K89.44%-60.58K15.55%-130.63K87.60%-325.46K
Minority interest income
Net income attributable to the parent company -231.04%-113.72K54.84%-313.98K-147.77%-150.11K54.28%-59.73K78.56%-69.79K80.76%-34.35K81.26%-695.2K89.44%-60.58K15.55%-130.63K87.60%-325.46K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -231.04%-113.72K54.84%-313.98K-147.77%-150.11K54.28%-59.73K78.56%-69.79K80.76%-34.35K81.26%-695.2K89.44%-60.58K15.55%-130.63K87.60%-325.46K
Basic earnings per share 00-0.00030083.33%-0.00195.24%-0.020099.25%-0.01
Diluted earnings per share 00-0.00030083.33%-0.00195.24%-0.020099.25%-0.01
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -